Canada Begins COVID-19 Vaccine Assessment

Massachusetts based Moderna, Inc., announced the initiation of a rolling submission to Health Canada for mRNA-1273, the Company’s vaccine candidate against COVID-19. The rolling submission has been accepted under the Canadian Minister of Health's Interim Order, which permits companies to submit safety and efficacy data and information as they become available.

This rolling review process allows Health Canada to begin its assessment using the information submitted by the applicant and accept new evidence as it becomes available until the application is deemed complete. Following the authorization of any vaccine submission, Health Canada stated it 'will publish the evidence used in making its decision for transparency.'

Previously, the Canadian Government increased its confirmed order commitment to 20 million doses of the mRNA-1273 vaccine candidate during September 2020.